Skip to content

Clinical trials

Phase 1/2 Bone Marrow Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Marrow Diseases Phase: Phase 1/2 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20121
20131
20141
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ariad Pharmaceuticals1
Constellation Pharmaceuticals1
Groupe Francophone des Myelodysplasies1
NS Pharma, Inc.1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1
Thomas Jefferson University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Marrow Diseases7
Myeloproliferative Disorders6
Hematologic Diseases5
Myelodysplastic Syndromes4
Primary Myelofibrosis3
Thrombocythemia, Essential3
Leukemia2
Neoplasms2
Neoplasms by Histologic Type2
Polycythemia Vera2

Trials

Showing 26 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.